Press release
- Helio Diagnostics
- Sep 21
- 1 min read
Helio Diagnostics: A European CDMO dedicated to In Vitro Diagnostics
Marseille, France – September 22, 2025 – Helio Diagnostics, a European leader in end-to-end Contract Development and Manufacturing (CDMO) services for In Vitro Diagnostics (IVD), was founded by seasoned entrepreneurs. Under the leadership of CEO Stéphane Debono, the company is supported by a Board of Directors bringing together Corinne Danan, Philippe Dhamelincourt, Vincent Fert, and Fabienne Hermitte.
“Our goal is to become a reference European CDMO in IVD outsourcing, making innovation operational” said Stéphane Debono, CEO. “The diagnostic industry is expanding rapidly, and clients need partners who combine technical depth with operational agility. With our experience and pure focus on IVD, Helio Diagnostics is ideally positioned to become a trusted partner to the world’s leading diagnostic companies.”
...